Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib

被引:26
作者
Liem, Ylian S. [1 ]
Bode, Lars [2 ,3 ]
Freeze, Hudson H. [2 ,3 ]
Leebeek, Frank W. G. [1 ]
Zandbergen, Adrienne A. M. [1 ]
Wilson, J. H. Paul [1 ]
机构
[1] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 CE Rotterdam, Netherlands
[2] Burnham Inst Med Res, Tumor Microenvironm Program, La Jolla, CA USA
[3] Burnham Inst Med Res, Glycobiol & Carbohydrate Chem Grp 1, La Jolla, CA USA
来源
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2008年 / 5卷 / 04期
关键词
congenital disorders of glycosylation; glycoproteins; heparin; protein-losing enteropathy; therapy;
D O I
10.1038/ncpgasthep1061
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background A 22-year-old female presented with edema, diarrhea, hypoalbuminemia and pancytopenia. She had previously been diagnosed with congenital disorder of glycosylation type Ib, and had a history of congenital hepatic fibrosis, portal hypertension and esophageal varices. In the past she had refused mannose therapy because of associated diarrhea and abdominal pain. Investigations Laboratory examinations, abdominal ultrasonography, bacterial and viral cultures of blood, urine and stools, double-balloon enteroscopy and fecal excretion test using Cr-51-labeled albumin. Diagnosis Protein-losing enteropathy. Management Infusion of albumin followed by intravenous and subcutaneous therapy with unfractionated heparin.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 19 条
[1]
[Anonymous], Online Mendelian Inheritance in Man
[2]
Heparin therapy and reversal of protein-losing enteropathy in a case with congenital heart disease [J].
Bendayán, I ;
Casaldaliga, J ;
Castelló, F ;
Miró, L .
PEDIATRIC CARDIOLOGY, 2000, 21 (03) :267-268
[3]
Applied glycoproteomics - approaches to study genetic-environmental collisions causing protein-losing enteropathy [J].
Bode, L ;
Freeze, HH .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (04) :547-559
[4]
Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy [J].
Bode, L ;
Murch, S ;
Freeze, HH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (12) :7809-7815
[5]
Heparan sulfate depletion amplifies TNF-α-induced protein leakage in an in vitro model of protein-losing enteropathy [J].
Bode, L ;
Eklund, EA ;
Murch, S ;
Freeze, HH .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (05) :G1015-G1023
[6]
Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function [J].
Bode, Lars ;
Salvestrini, Camilla ;
Park, Pyong Woo ;
Li, Jin-Ping ;
Esko, Jeffrey D. ;
Yamaguchi, Yu ;
Murch, Simon ;
Freeze, Hudson H. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) :229-238
[7]
Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms [J].
Bruewer, M ;
Luegering, A ;
Kucharzik, T ;
Parkos, CA ;
Madara, JL ;
Hopkins, AM ;
Nusrat, A .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :6164-6172
[8]
Modulation of barrier function of small intestinal epithelial cells by lamina propria fibroblasts in response to lipopolysaccharide:: Possible role of TNFα in inducing barrier dysfunction [J].
Chakravortty, D ;
Kumar, KSN .
MICROBIOLOGY AND IMMUNOLOGY, 1999, 43 (06) :527-533
[9]
Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type IA, Ib, and Ic [J].
Damen, G ;
de Klerk, H ;
Huijmans, J ;
den Hollander, J ;
Sinaasappel, M .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 38 (03) :282-287
[10]
Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation [J].
Donnelly, JP ;
Rosenthal, A ;
Castle, VP ;
Holmes, RD .
JOURNAL OF PEDIATRICS, 1997, 130 (03) :474-478